West Pharmaceutical expects full-year earnings in the range of $6 to $6.20 per share, with revenue in the range of $2.88 billion to $2.91 billion. This story was generated by Automated Insights ( http ...
Equitable owner of the mall property,  Peter Abrams, of Abrams Realty and Development, and Exton Square LLC.,  plans call for ...
The Eagleview community in Exton is one of the 20 development projects across the Philadelphia region to watch in 2025, write ...
Exton’s Hunt Auctions once again partnered with the NFL to auction off rare historical football items before this year’s ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.